Siqing Fu, M.D., Ph.D.
Department of Investigational Cancer Therapeutics, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Research Interests
Novel design for Phase I/II clinical trials Phase I/II clinical trials Chemosensitization via biological targeting agents Epigenetic Therapy Complementary medicine for cancer treatment
Click here for the most up-to-date list of Dr. Fu's publications.
Education & Training
Degree-Granting Education
1996 | The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX, USA, PHD, Molecular Biology |
1985 | Tongji Medical University, Wuhan, USA, MD, Medicine |
Postgraduate Training
2001-2004 | Clinical Fellowship, Section of Hematology and Medical Oncology, University of Rochester, Rochester, NY |
1999-2001 | Residency, Departmental of Internal Medicine, University of Rochester, Rochester, NY |
1998-1999 | Internship, Department of Internal Medicine, Hospital of Saint Raphael, New Haven, CT |
1996-1998 | Postdoctoral Associate, Section of Medical Oncology, Yale University School of Medicine, New Haven, CT |
1990-1996 | Project Investigator, The University of Texas MD Anderson Cancer Center, Houston, TX |
Board Certifications
2004 | Hematology |
2004 | Medical Oncology |
2001 | Internal Medicine |
1995 | ECFMG |
Experience & Service
Academic Appointments
Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2018
Patient Reviews
CV information above last modified December 02, 2024